Process and outcome of day clinic and inpatient psychotherapy in severe bulimia nervosa: a randomised-controlled trial

ISRCTN ISRCTN30183796
DOI https://doi.org/10.1186/ISRCTN30183796
Protocol serial number ZE 520/4-1
Sponsor German Research Foundation (Deutsche Forschungsgemeinschaft) (DFG) (Germany)
Funder German Research Foundation (Deutsche Forschungsgemeinschaft) (DFG) (Germany) - (ref: ZE 520/4-1_
Submission date
30/05/2005
Registration date
23/08/2005
Last edited
29/09/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Almut Zeeck
Scientific

Dept. of Psychosomatic Medicine and Psychotherapy
University of Freiburg
Hauptstrasse 8
Freiburg
79104
Germany

Phone +49 (0)761 2706806
Email almut.zeeck@uniklinik-freiburg.de

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study objectives1. 3 month follow-up:
1.1. Inpatients will suffer from more relapses after discharge (bulimic
symptoms)
1.2. Inpatients will show less feelings of specific self-efficiacy compared
with day clinic patients between discharge and 3-month-follow-up
1.3. Day clinic patients will show some improvement in social adjustment whereas after inpatient treatment there will be no change

2. 12 month follow up:
2.1. Both groups will show comparable results in general and specific
pathology
2.2. Day clinic patients will show more improvements in social adjustment
2.3. Day clinic patients will be more satisfied with treatment in retrospect
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSevere bulimia nervosa
Intervention3 month of day clinic or inpatient treatment (multimodal treatment) with the same treatment elements in similar quantity in both conditions (individual and group therapy, work with eating diaries, rounds, art therapy, body therapy etc.). The treatment concept is psychodynamic, integrating cognitive-behavioral and family-oriented elements.
Intervention typeOther
Primary outcome measure(s)

1. Eating- Disorder-Inventory (EDI-II) (scale 2: bulimia)
2. Symptom-Check-List (SCL-90-R)
3. Global Severity Index (GSI)
4. Self-Efficiacy-Questionnaire; Social Adjustment Scale (SAS) (total score)

Key secondary outcome measure(s)

Not provided at time of registration

Completion date31/03/2006

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration60
Key inclusion criteria1. Bulimia nervosa: International Statistical Classification of Diseases and Related Health Problems, tenth revision (ICD 10) / Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM IV)
2. Age >17
3. Indication for day clinic/inpatient treatment
3.1. failure of outpatient psychotherapy
3.2. chronicity
3.3. severe symptom expression
3.4. severe comorbidity
Key exclusion criteria1. Severe, acute somatic complications
2. Psychosis
3. Severe addiction (detoxification is needed)
4. Acute suicidality
5. Clinic can not be reached within a reasonable time (>60 minutes travel time)
Date of first enrolment01/01/2003
Date of final enrolment31/03/2006

Locations

Countries of recruitment

  • Germany

Study participating centre

Dept. of Psychosomatic Medicine and Psychotherapy
Freiburg
79104
Germany

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/08/2009 Yes No